PortfoliosLab logoPortfoliosLab logo
IXJ vs. ARKG
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

IXJ vs. ARKG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares Global Healthcare ETF (IXJ) and ARK Genomic Revolution Multi-Sector ETF (ARKG). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IXJ achieves a 3.85% return, which is significantly lower than ARKG's 33.10% return. Both investments have delivered pretty close results over the past 10 years, with IXJ having a 8.22% annualized return and ARKG not far ahead at 8.25%.


IXJ

1D
-0.97%
1M
-1.26%
6M
2.41%
YTD
3.85%
1Y
21.78%
3Y*
7.07%
5Y*
4.53%
10Y*
8.22%
ALL TIME*
7.37%

ARKG

1D
-1.78%
1M
-10.14%
6M
26.72%
YTD
33.10%
1Y
63.67%
3Y*
1.35%
5Y*
-14.38%
10Y*
8.25%
ALL TIME*
6.19%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$92.48M$118.08M$121.77M
$16.06M$16.61M$23.38M

IXJ vs. ARKG - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
IXJ
iShares Global Healthcare ETF
3.85%14.99%0.55%3.62%-4.94%19.60%12.74%23.23%2.83%20.44%
ARKG
ARK Genomic Revolution Multi-Sector ETF
33.10%23.04%-28.24%16.22%-53.90%-33.92%180.40%44.00%-1.26%46.61%

Correlation

The correlation between IXJ and ARKG is 0.40, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.40

Correlation (3Y)
Balances recent behavior with more history.

0.45

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.48

Correlation (10Y)
Provides a long-term view across more market conditions.

0.52

Correlation (All Time)
Calculated using the full available price history since Oct 31, 2014

0.53

The correlation between IXJ and ARKG shifts across timeframes, from 0.40 (1 year) to 0.53 (all time), reflecting how their relationship changes across market environments.

IXJ vs. ARKG - Sectors Allocation Comparison


Sectors
IXJ
ARKG

Healthcare

99.2%
97.3%

Consumer Defensive

0.5%

-

Technology

0.4%
2.0%

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Energy

-

-

Financial Services

-

0.9%

Industrials

-

-

Real Estate

-

-

Utilities

-

-

Healthcare

IXJ
99.2%
ARKG
97.3%

Consumer Defensive

IXJ
0.5%
ARKG

-

Technology

IXJ
0.4%
ARKG
2.0%

Basic Materials

IXJ

-

ARKG

-

Communication Services

IXJ

-

ARKG

-

Consumer Cyclical

IXJ

-

ARKG

-

Energy

IXJ

-

ARKG

-

Financial Services

IXJ

-

ARKG
0.9%

Industrials

IXJ

-

ARKG

-

Real Estate

IXJ

-

ARKG

-

Utilities

IXJ

-

ARKG

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IXJ vs. ARKG — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

IXJ
IXJ Risk / Return Rank: 6161
Overall Rank
IXJ Sharpe Ratio Rank: 6666
Sharpe Ratio Rank
IXJ Sortino Ratio Rank: 7474
Sortino Ratio Rank
IXJ Omega Ratio Rank: 6262
Omega Ratio Rank
IXJ Calmar Ratio Rank: 6060
Calmar Ratio Rank
IXJ Martin Ratio Rank: 4545
Martin Ratio Rank

ARKG
ARKG Risk / Return Rank: 5959
Overall Rank
ARKG Sharpe Ratio Rank: 6262
Sharpe Ratio Rank
ARKG Sortino Ratio Rank: 6666
Sortino Ratio Rank
ARKG Omega Ratio Rank: 5656
Omega Ratio Rank
ARKG Calmar Ratio Rank: 6565
Calmar Ratio Rank
ARKG Martin Ratio Rank: 4747
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

IXJ vs. ARKG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Global Healthcare ETF (IXJ) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


IXJARKGDifference
Sharpe ratioReturn per unit of total volatility

+0.05

Sortino ratioReturn per unit of downside risk

+0.22

Omega ratioGain probability vs. loss probability

1.27

1.25

+0.02

Calmar ratioReturn relative to maximum drawdown

2.10

2.26

-0.16

Martin ratioReturn relative to average drawdown

4.99

5.42

-0.42

IXJ vs. ARKG - Sharpe Ratio Comparison

The current IXJ Sharpe Ratio is 1.50, which is comparable to the ARKG Sharpe Ratio of 1.45. The chart below compares the historical Sharpe Ratios of IXJ and ARKG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

IXJ vs. ARKG - Drawdown Comparison

The maximum IXJ drawdown since its inception was -40.60%, smaller than the maximum ARKG drawdown of -83.59%. Use the drawdown chart below to compare losses from any high point for IXJ and ARKG.


Loading charts...

Drawdown Indicators


IXJARKGDifference

Max Drawdown

Largest peak-to-trough decline

-40.60%

-83.59%

+42.99%

Max Drawdown (1Y)

Largest decline over 1 year

-10.78%

-27.51%

+16.73%

Max Drawdown (3Y)

Largest decline over 3 years

-18.14%

-46.45%

+28.31%

Max Drawdown (5Y)

Largest decline over 5 years

-18.14%

-79.26%

+61.12%

Max Drawdown (10Y)

Largest decline over 10 years

-27.35%

-83.59%

+56.24%

Current Drawdown

Current decline from peak

-2.52%

-65.50%

+62.98%

Average Drawdown

Average peak-to-trough decline

-6.90%

-36.27%

+29.37%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.52%

11.46%

-6.94%

Volatility

IXJ vs. ARKG - Volatility Comparison

The current volatility for iShares Global Healthcare ETF (IXJ) is 5.66%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 10.47%. This indicates that IXJ experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IXJARKGDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.66%

10.47%

-4.81%

Volatility (6M)

Calculated over the trailing 6-month period

11.61%

31.28%

-19.67%

Volatility (1Y)

Calculated over the trailing 1-year period

15.38%

43.11%

-27.73%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

14.50%

46.17%

-31.67%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

15.74%

41.44%

-25.70%

IXJ vs. ARKG - Expense Ratio Comparison

IXJ has a 0.40% expense ratio, which is lower than ARKG's 0.75% expense ratio.


Dividends

IXJ vs. ARKG - Dividend Comparison

IXJ's dividend yield for the trailing twelve months is around 1.44%, while ARKG has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
ARKG
ARK Genomic Revolution Multi-Sector ETF
0.00%0.00%0.00%0.00%0.00%0.62%0.85%3.14%0.82%1.34%0.00%0.00%
IXJ
iShares Global Healthcare ETF
1.44%1.40%1.50%1.38%1.17%1.12%1.27%1.42%2.11%1.46%1.73%2.85%

Frequently Asked Questions


IXJ and ARKG have a correlation of 0.40, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ARKG has higher volatility (10.47%) compared to IXJ (5.66%). In terms of maximum drawdown, IXJ dropped -40.60% vs ARKG's -83.59%.

On 10-year performance, ARKG leads with 8.25% vs 8.22% for IXJ. On fees, IXJ is cheaper at 0.40% per year. On volatility, IXJ has been the lower-risk option at 5.66%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, ARKG has performed better with a 8.25% return vs 8.22%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

IXJ is cheaper with a 0.40% expense ratio, compared with 0.75% for ARKG.

IXJ has the higher dividend yield at 1.44%, compared with 0.00% for ARKG.

They also come from different issuers: iShares and ARK. Their fees differ too: 0.40% for IXJ and 0.75% for ARKG.

IXJ currently has the higher Sharpe Ratio (1.50 vs 1.45), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IXJ and ARKG

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer